TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
出版年份 2021 全文链接
标题
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
作者
关键词
-
出版物
Cancer Cell International
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-16
DOI
10.1186/s12935-021-02191-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
- (2021) Cunte Chen et al. Frontiers in Pharmacology
- Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia
- (2021) Kehan Li et al. Biomarker Research
- The prognostic significance of del6q23 in chronic lymphocytic leukemia
- (2021) Hadiyah Y. Audil et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma
- (2021) Cunte Chen et al. Experimental Hematology & Oncology
- High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B‐cell lymphomas
- (2020) Visar Vela et al. HEMATOLOGICAL ONCOLOGY
- Expression patterns of immune checkpoints in acute myeloid leukemia
- (2020) Cunte Chen et al. Journal of Hematology & Oncology
- Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
- (2020) Si-Ye Chen et al. LEUKEMIA
- ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
- (2019) Yalu Liu et al. Cancer Cell International
- Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas
- (2019) Fredrik Ellin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
- (2019) Fang Liu et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Aggressive T‐ cell Lymphomas: 2019 updates on diagnosis, risk stratification and management
- (2019) Jasmine M. Zain AMERICAN JOURNAL OF HEMATOLOGY
- Molecular pathogenic pathways in extranodal NK/T cell lymphoma
- (2019) Sanjay de Mel et al. Journal of Hematology & Oncology
- The potential role of TNFAIP3 in malignant transformation of gastric carcinoma
- (2019) Bing Du et al. PATHOLOGY RESEARCH AND PRACTICE
- T-cell therapies for T-cell lymphoma
- (2019) Keri Toner et al. CYTOTHERAPY
- The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma
- (2019) Shengnan Zhang et al. Cancer Cell International
- Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients
- (2019) Gregorio Barilà et al. LEUKEMIA
- Clinicopathologic implications of TNFAIP3/A20 deletions in extranodal NK/T-cell lymphoma
- (2018) Hyein Ahn et al. GENES CHROMOSOMES & CANCER
- Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
- (2018) Kerstin Wenzl et al. Blood Cancer Journal
- A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1
- (2017) Ji-Hyung Lee et al. NATURE CELL BIOLOGY
- Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
- (2017) Manli Jiang et al. Expert Review of Hematology
- The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
- (2016) Dai Chihara et al. BRITISH JOURNAL OF HAEMATOLOGY
- TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy
- (2015) Yu Matsuzawa et al. Autophagy
- Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis
- (2015) Lihua Zhu et al. Journal of Translational Medicine
- Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia
- (2014) Lihua Zhu et al. Hematology
- A20-mediated negative regulation of canonical NF-κB signaling pathway
- (2013) Rajeshree Pujari et al. IMMUNOLOGIC RESEARCH
- Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment
- (2013) Jin Ho Paik et al. LEUKEMIA & LYMPHOMA
- The role of A20 in the pathogenesis of lymphocytic malignancy
- (2012) Fan Zhang et al. Cancer Cell International
- Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer
- (2012) Jonas Ungerbäck et al. CARCINOGENESIS
- Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups
- (2012) Rika Kihara et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
- (2011) F C M Braun et al. LEUKEMIA
- Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases
- (2010) B. Bareau et al. HAEMATOLOGICA
- The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- (2009) U. Novak et al. BLOOD
- The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms
- (2009) James W. Vardiman CHEMICO-BIOLOGICAL INTERACTIONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started